Articles with "rats dogs" as a keyword



Photo from wikipedia

Animal models for analysis of hypersensitivity reactions to Shuanghuanglian injection.

Sign Up to like & get
recommendations!
Published in 2020 at "Molecular immunology"

DOI: 10.1016/j.molimm.2020.03.014

Abstract: Among a variety of traditional Chinese medicines, Shuanghuanglian injection (SHLI), has the highest incidence of injection-induced immediate hypersensitivity reactions (IHRs). However, the precise mechanisms of SHLI-induced IHRs remain to be understood. In the present study,… read more here.

Keywords: shuanghuanglian injection; hypersensitivity reactions; injection; rats dogs ... See more keywords
Photo from wikipedia

Cross-species comparison of the metabolism and excretion of selexipag

Sign Up to like & get
recommendations!
Published in 2019 at "Xenobiotica"

DOI: 10.1080/00498254.2018.1444814

Abstract: Abstract 1. The metabolism of the prostacyclin receptor agonist selexipag (NS-304; ACT-293987) and its active metabolite MRE-269 (ACT-333679) has been investigated in liver microsomes and hepatocytes of rats, dogs, and monkeys. MRE-269 formation is the… read more here.

Keywords: cross species; metabolism; selexipag; rats dogs ... See more keywords
Photo by elisasch from unsplash

Metabolism and disposition in rats, dogs, and humans of erdafitinib, an orally administered potent pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor

Sign Up to like & get
recommendations!
Published in 2020 at "Xenobiotica"

DOI: 10.1080/00498254.2020.1821123

Abstract: Abstract This article describes in vivo biotransformation and disposition of erdafitinib following single oral dose of 3H-erdafitinib and 14C-erdafitinib to intact and bile duct-cannulated (BC) rats (4 mg/kg), 3H-erdafitinib to intact dogs (0.25 mg/kg), and 14C-erdafitinib to… read more here.

Keywords: disposition rats; erdafitinib major; metabolism disposition; rats dogs ... See more keywords
Photo by jaredmurray from unsplash

Pharmacokinetics and mass balance of vericiguat in rats and dogs and distribution in rats

Sign Up to like & get
recommendations!
Published in 2022 at "Xenobiotica"

DOI: 10.1080/00498254.2022.2082899

Abstract: Abstract Vericiguat is a soluble guanylate cyclase stimulator. The pharmacokinetics, absorption, metabolism, and excretion properties of vericiguat in rats and dogs and the distribution in rats are reported. [14C]-labelled vericiguat was studied in intact and… read more here.

Keywords: vericiguat; administration; dogs distribution; distribution rats ... See more keywords
Photo by photo_glory from unsplash

Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen Metabolism

Sign Up to like & get
recommendations!
Published in 2022 at "Drug Metabolism and Disposition"

DOI: 10.1124/dmd.122.000929

Abstract: Endoxifen (ENDX) is an active metabolite of tamoxifen (TAM), a drug commonly used for the treatment of estrogen receptor–positive breast cancer and metabolized by CYP2D6. Genetic or drug-induced reductions in CYP2D6 activity decrease plasma ENDX… read more here.

Keywords: endx; metabolism; female rats; overcome limitations ... See more keywords
Photo by jaredmurray from unsplash

Absorption, Metabolism, and Excretion of Taselisib (GDC-0032), a Potent β-Sparing PI3K Inhibitor in Rats, Dogs, and Humans

Sign Up to like & get
recommendations!
Published in 2023 at "Drug Metabolism and Disposition"

DOI: 10.1124/dmd.122.001096

Abstract: Taselisib (also known as GDC-0032) is a potent and selective phosphoinositide 3-kinase (PI3K) inhibitor that displays greater selectivity for mutant PI3Kα than wild-type PI3Kα. To better understand the absorption, distribution, metabolism, and excretion properties of… read more here.

Keywords: metabolism; taselisib; rats dogs; excretion taselisib ... See more keywords
Photo by jaredmurray from unsplash

A novel oral formulation of the melanocortin-1 receptor agonist PL8177 resolves inflammation in preclinical studies of inflammatory bowel disease and is gut restricted in rats, dogs, and humans

Sign Up to like & get
recommendations!
Published in 2023 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2023.1083333

Abstract: Introduction PL8177 is a potent and selective agonist of the melanocortin 1 receptor (MC1R). PL8177 has shown efficacy in reversing intestinal inflammation in a cannulated rat ulcerative colitis model. To facilitate oral delivery, a novel,… read more here.

Keywords: pl8177; formulation; rats dogs; melanocortin receptor ... See more keywords
Photo from wikipedia

Preclinical studies of NOS inhibitor T1059 vasopressor activity on the models of acute hemorrhagic shock in rats and dogs

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Pharmacology"

DOI: 10.3389/fphar.2022.995272

Abstract: The development of new effective and safe vasopressors is one of the ways to increase the effectiveness of the treatment of hypotensive disorders, the severe forms of which remain a common cause of death in… read more here.

Keywords: vasopressor activity; rats dogs; inhibitor; t1059 ... See more keywords
Photo by jaredmurray from unsplash

Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model

Sign Up to like & get
recommendations!
Published in 2022 at "Viruses"

DOI: 10.3390/v14102268

Abstract: We earlier reported substantial progress in designing gp120 antagonists. Notably, we discovered that NBD-14189 is not only the most active gp120 antagonist but also shows antiviral activity against HIV-1 Reverse Transcriptase (RT). We also confirmed… read more here.

Keywords: hiv; 14189 rats; rats dogs; inhibitor ... See more keywords